198 related articles for article (PubMed ID: 9002124)
1. Use of fluoroquinolones as prophylactic agents in patients with neutropenia.
Patrick CC
Pediatr Infect Dis J; 1997 Jan; 16(1):135-9; discussion 160-2. PubMed ID: 9002124
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future.
Young LS
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):93-7. PubMed ID: 3132393
[TBL] [Abstract][Full Text] [Related]
3. Use of selective decontamination in the prevention of infection after accidental irradiation. A review.
Brook I; Ledney GD
Prehosp Disaster Med; 1993; 8(1):85-8. PubMed ID: 10155457
[TBL] [Abstract][Full Text] [Related]
4. The use of fluoroquinolones in neutropenic patients--analysis of adverse effects.
Rubinstein E; Potgieter P; Davey P; Norrby SR
J Antimicrob Chemother; 1994 Jul; 34(1):7-19. PubMed ID: 7961217
[TBL] [Abstract][Full Text] [Related]
5. Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.
Maschmeyer G
Drugs; 1993; 45 Suppl 3():73-80. PubMed ID: 7689455
[TBL] [Abstract][Full Text] [Related]
6. Ciprofloxacin prophylaxis in high risk neutropenic patients: effects on outcomes, antimicrobial therapy and resistance.
Garnica M; Nouér SA; Pellegrino FL; Moreira BM; Maiolino A; Nucci M
BMC Infect Dis; 2013 Jul; 13():356. PubMed ID: 23899356
[TBL] [Abstract][Full Text] [Related]
7. Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Acta Haematol; 1998; 99(4):206-11. PubMed ID: 9644298
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
9. The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.
Del Favero A; Menichetti F
Eur J Cancer; 1993; 29A Suppl 1():S2-6. PubMed ID: 8427721
[TBL] [Abstract][Full Text] [Related]
10. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
[TBL] [Abstract][Full Text] [Related]
11. Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial.
Lee DG; Choi SM; Choi JH; Yoo JH; Park YH; Kim YJ; Lee S; Min CK; Kim HJ; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
Korean J Intern Med; 2002 Mar; 17(1):38-44. PubMed ID: 12014211
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
Gafter-Gvili A; Fraser A; Paul M; Leibovici L
Ann Intern Med; 2005 Jun; 142(12 Pt 1):979-95. PubMed ID: 15968013
[TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolones, antimicrobial resistance and neutropenic cancer patients.
Bow EJ
Curr Opin Infect Dis; 2011 Dec; 24(6):545-53. PubMed ID: 22001945
[TBL] [Abstract][Full Text] [Related]
14. Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance.
Prentice HG; Hann IM; Nazareth B; Paterson P; Bhamra A; Kibbler CC
Br J Haematol; 2001 Oct; 115(1):46-52. PubMed ID: 11722408
[TBL] [Abstract][Full Text] [Related]
15. [Fluoroquinolones to prevent bacterial infection in children with chemotherapy induced neutropenia: is it reasonable?].
Dubos F; Delebarre M; Lagrée M
Arch Pediatr; 2013 Nov; 20 Suppl 3():S90-3. PubMed ID: 24360309
[TBL] [Abstract][Full Text] [Related]
16. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
17. Use of fluoroquinolones for empirical management of febrile neutropenia in pediatric cancer patients.
Freifeld A; Pizzo P
Pediatr Infect Dis J; 1997 Jan; 16(1):140-5; discussion 145-6, 160-2. PubMed ID: 9002125
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial prophylaxis.
Cruciani M
Int J Antimicrob Agents; 2000 Oct; 16(2):123-5. PubMed ID: 11053792
[TBL] [Abstract][Full Text] [Related]
19. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
[TBL] [Abstract][Full Text] [Related]
20. [Prophylaxis with fluoroquinolones in patients with neutropenia].
Brodsky AL; Minissale CJ; Melero MJ; Sánchez Avalos JC
Medicina (B Aires); 1993; 53(5):401-7. PubMed ID: 8201928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
